REGENXBIO Inc. (RGNX)
USD 6.02
(-2.35%)
USD 6.02
(-2.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -218.4 Million | -207.48 Million | 218.87 Million | -54.06 Million | -107.7 Million | 104.64 Million |
| Net Income | -263.49 Million | -280.32 Million | 127.84 Million | -111.25 Million | -94.73 Million | 99.93 Million |
| Depreciation & Amortization | 17.32 Million | 12.9 Million | 9.56 Million | 8.4 Million | 7.15 Million | 3.98 Million |
| Deferred income taxes | -1.14 Million | - | -1.91 Million | 3.84 Million | -38.97 Million | 794 Thousand |
| Stock-based compensation | 40.26 Million | 40.78 Million | 38.8 Million | 31.94 Million | 26.85 Million | 16.64 Million |
| Change in working capital | -10.88 Million | 13.97 Million | 40.21 Million | 14.21 Million | -5.32 Million | -7.77 Million |
| Other non-cash items | -469 Thousand | 5.15 Million | 4.36 Million | -1.22 Million | -2.68 Million | -8.93 Million |
| Investing Cash Flow | 190.94 Million | -11.92 Million | -406.64 Million | 122.75 Million | 93.55 Million | -279.35 Million |
| Investments in PPE | -9.96 Million | -30.72 Million | -84.17 Million | -26.86 Million | -11.72 Million | -13.27 Million |
| Acquisitions | -1.97 Million | - | -4.99 Million | -149.62 Million | -295.98 Million | -179.71 Million |
| Investment purchases | -86.56 Million | -184.87 Million | -498.14 Million | -123.04 Million | -190.73 Million | -445.82 Million |
| Sales/Maturities of investments | 287.46 Million | 203.67 Million | 175.67 Million | 272.66 Million | 296.01 Million | 179.74 Million |
| Other Investing Activities | 1.97 Million | - | 4.99 Million | 149.62 Million | 295.98 Million | 179.71 Million |
| Financing Cash Flow | -34.96 Million | -28.84 Million | 195.25 Million | 200.21 Million | 8.37 Million | 204.44 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -419 Thousand | -284 Thousand | -2000.00 | 1.79 Million | 1.31 Million | 847 Thousand |
| Common Stock Issuance | 7.75 Million | 4.54 Million | 222.1 Million | 7.42 Million | 8.37 Million | 204.44 Million |
| Other Financing Activities | -34.54 Million | -28.55 Million | 195.25 Million | 200.21 Million | -1.31 Million | 204.44 Million |
| Accounts receivables | 3.93 Million | 4.82 Million | 14.11 Million | -9.89 Million | -8.62 Million | -16.8 Million |
| Accounts payables | -2.79 Million | 18.79 Million | -2.3 Million | 3.87 Million | 1.52 Million | -218 Thousand |
| Inventory | - | - | 29.3 Million | 17.85 Million | 2.36 Million | 5.34 Million |
| Other working capital | -12.03 Million | -9.63 Million | -899 Thousand | 2.39 Million | -600 Thousand | 3.9 Million |
| Cash at beginning of period | 96.95 Million | 347.23 Million | 339.75 Million | 70.84 Million | 76.61 Million | 46.88 Million |
| Cash at end of period | 34.52 Million | 98.98 Million | 347.23 Million | 339.75 Million | 70.84 Million | 76.61 Million |
| Capital Expenditure | -9.96 Million | -30.72 Million | -84.17 Million | -26.86 Million | -11.72 Million | -13.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -62.43 Million | -248.25 Million | 7.48 Million | 268.91 Million | -5.77 Million | 29.73 Million |
| Free Cash Flow | -228.36 Million | -238.21 Million | 134.7 Million | -80.93 Million | -119.42 Million | 91.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -52.98 Million | -63.33 Million | -62.88 Million | -263.49 Million | -61.86 Million | -72.06 Million |
| Depreciation & Amortization | 4.05 Million | 4.17 Million | 4.33 Million | 17.32 Million | 4.37 Million | 4.43 Million |
| Deferred income taxes | - | - | -12.41 Million | -1.14 Million | -2.33 Million | 380 Thousand |
| Stock-based compensation | 9.43 Million | 9.6 Million | 8.33 Million | 40.26 Million | 10.21 Million | 10.5 Million |
| Change in working capital | -4.03 Million | -8.15 Million | 9.22 Million | -10.88 Million | -623 Thousand | 10.12 Million |
| Other non-cash items | 37.38 Million | 2.57 Million | 12.65 Million | -469 Thousand | 831 Thousand | -705 Thousand |
| Investing Cash Flow | -268 Thousand | 13.18 Million | 33.97 Million | 190.94 Million | 38.65 Million | 55.21 Million |
| Investments in PPE | -474 Thousand | -557 Thousand | -1.12 Million | -9.96 Million | -1.43 Million | -2.57 Million |
| Acquisitions | - | - | -35.1 Million | -1.97 Million | -40.09 Million | -57.79 Million |
| Investment purchases | -82.52 Million | -55.19 Million | -18.63 Million | -86.56 Million | -18.13 Million | -49.79 Million |
| Sales/Maturities of investments | 82.73 Million | 68.93 Million | 53.73 Million | 287.46 Million | 58.22 Million | 107.59 Million |
| Other Investing Activities | 206 Thousand | 13.74 Million | 35.1 Million | 1.97 Million | 40.09 Million | 57.79 Million |
| Financing Cash Flow | -9.44 Million | 120.72 Million | -11.96 Million | -34.96 Million | -4.8 Million | -9.16 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 411 Thousand | - | -419 Thousand | 1.24 Million | - |
| Common Stock Issuance | -160 Thousand | 132.86 Million | -210 Thousand | 7.75 Million | 6.15 Million | 749 Thousand |
| Other Financing Activities | -9.28 Million | -12.13 Million | -11.96 Million | -34.54 Million | -4.8 Million | -9.16 Million |
| Accounts receivables | -6.89 Million | 9.17 Million | 3.36 Million | 3.93 Million | -6.54 Million | -2.38 Million |
| Accounts payables | -14.91 Million | 8.46 Million | 1.22 Million | -2.79 Million | 10.09 Million | -11 Million |
| Inventory | - | - | -20.12 Million | - | -4.17 Million | 24.29 Million |
| Other working capital | 17.77 Million | -25.79 Million | 4.63 Million | -12.03 Million | -6000.00 | -779 Thousand |
| Cash at beginning of period | 112.97 Million | 34.52 Million | 53.04 Million | 96.95 Million | 70.85 Million | 72.12 Million |
| Cash at end of period | 57.76 Million | 112.97 Million | 34.52 Million | 34.52 Million | 55.3 Million | 70.85 Million |
| Capital Expenditure | -474 Thousand | -557 Thousand | -1.12 Million | -9.96 Million | -1.43 Million | -2.57 Million |
| Effect of forex changes on cash | - | - | 225 Thousand | - | -29.97 Million | - |
| Net cash flow / Change in cash | -55.21 Million | 78.45 Million | -18.52 Million | -62.43 Million | -15.55 Million | -1.26 Million |
| Free Cash Flow | -45.97 Million | -56.01 Million | -41.88 Million | -228.36 Million | -50.84 Million | -49.89 Million |
2495
RGL
SOBS
EYE
NL
CTUK